Lifestyle interventions

Lifestyle interventions has been studied in 81 papers since 2014: 4 trials and 1 observational study in people, 73 reviews; 57 in the past year. The newest paper, Nov 19, 2026: “Recomendaciones sobre el estilo de vida. Actualización PAPPS 2026”.

Intervention

81 papers study it30 findingsUpdated

Research on it is growing 82% faster than aging research as a whole: 81 papers in the latest year counted

20 new papers in 30 daysSee all 81 papers on lifestyle interventions

At a glance

The findings reach people, from one lab or study. 11 independent labs in 5 countries.

“No significant intervention effects on brain structural or vascular outcomes were found.”
Targeting brain health in subjective cognitive decline: insights from a multidomain randomized controlled trialAging clinical and experimental research2025doi:10.1007/s40520-025-03062-z

1 of its findings points the other way.

Humans: a single group. Cells, worms or flies and mice: nothing yet.
  • 11 independent labs in 5 countries
  • 1 finding against
  • Funders: National Institutes of Health and others
  • 1 of 16 findings with company ties
  • Human trial4
  • Humans1
  • In silico2

Studies in people

3 studies gave lifestyle interventions to people and measured what changed.

What changedDesignPeopleSource

no change: Has no effect on NAD+

Treated cohortNature metabolism, May 14, 2026

no change: Has no effect on brain structural and vascular outcomes

Randomized trialone year134 peopleaged 60 to 80 yearsSCD participantsAging clinical and experimental research, May 14, 2025

up: Raises the risk of mortality+28% relative risk, p < 0.00688

Review of trials36 people pooledolder adultsOlder adultsmedRxiv : the preprint server for health sciences, Sep 29, 2023

What did studies of lifestyle interventions find?

16

Studies of lifestyle interventions measured 16 outcomes; the most studied is cardiovascular disease (3 studies).

Cardiovascular disease

downin humans3

3 studies
  1. Lifestyle interventions decrease cardiovascular disease in humans.

    Review

  2. Lifestyle interventions decrease cardiovascular disease in older individuals with MetS.

    Reviewin older individuals with MetS

  3. Lifestyle interventions protect against cardiovascular disease in humans.

    Review

More on Cardiovascular disease

Brain structural and vascular outcomes

no changein humans1

1 study
  1. Lifestyle interventions showed no clear effect on brain structural and vascular outcomes in humans.

    Human trialone year

  2. Lifestyle interventions showed no clear effect on brain structural and vascular outcomes in humans (subjective cognitive decline).

    Human trialsubjective cognitive declinebrainone year

Cardiometabolic risk factors

upin humans1

1 study
  1. Lifestyle interventions improve cardiometabolic risk factors in humans (cardiovascular–kidney–metabolic syndrome).

    Reviewcardiovascular–kidney–metabolic syndrome

DNAm-based measures of aging

no changein humans1

1 study
  1. Lifestyle interventions showed no clear effect on DNAm-based measures of aging in humans (Chronological-age clocks: SMD −0.04 (95% CI −0.31 to 0.24); phenotypic/mortality clocks: −0.17 (−0.42 to 0.09); DunedinPACE: −0.01 (−0.17 to 0.15)).

    Reviewn = 1,675

More on DNAm-based measures of aging

Leptin

downin humans1

1 study
  1. Lifestyle interventions decrease leptin in humans (clinically defined metabolic syndrome) (WMD −4.38 ng/mL, 95% CI −6.20 to −2.56).

    Reviewclinically defined metabolic syndrome

More on Leptin

Adiponectin

upin humans1

1 study
  1. Lifestyle interventions increase adiponectin in humans (clinically defined metabolic syndrome) (WMD 0.85 μg/mL, 95% CI 0.14 to 1.55).

    Reviewclinically defined metabolic syndrome

More on Adiponectin

Telomere length

no changein humans1

1 study
  1. Lifestyle interventions showed no clear effect on telomere length in humans (cancer survivors).

    Reviewcancer survivors

More on Telomere length

C-reactive protein

downin humans1

1 study
  1. Lifestyle interventions decrease C-reactive protein in humans (−0.52 mg/ml, 95% CI −0.72 to −0.33).

    Review

More on C-reactive protein

Cognitive function

upin humans1

1 study
  1. Lifestyle interventions improve cognitive function in humans (mild cognitive impairment or subjective cognitive decline) (SMD 1.49, 95% CI 1.06 to 1.93).

    Reviewmild cognitive impairment or subjective cognitive decline

NAD+

no changein humans1

1 study
  1. Lifestyle interventions showed no clear effect on NAD+ in humans.

    Human trialwhole blood

More on NAD+

All 16

What is lifestyle interventions linked with?

10

Studies link lifestyle interventions with 10 measures, among them mortality, Explicit inclusion of African immigrants and kidney-associated fat measures.

Mortality

downin humans1upin humans1RR 0.88

2 studies
  1. Lifestyle interventions raise the risk of mortality in humans (+28% relative risk, p < 0.00688).

    Human trialn = 36

  2. Lifestyle interventions lower the risk of mortality in humans (RR 0.88).

    Review

Explicit inclusion of African immigrants

mixedin humans1

1 study
  1. Lifestyle interventions are associated with explicit inclusion of African immigrants in humans (Lifestyle intervention trials targeting Black/African American adults in the US) (Only one of 43 eligible studies explicitly reported inclusion).

    ReviewLifestyle intervention trials targeting Black/African American adults in the US

Kidney-associated fat measures

mixedin humans1

1 study
  1. Lifestyle interventions are associated with kidney-associated fat measures in humans.

    Reviewkidney-associated adipose tissue

More on Kidney-associated fat measures

Stroke

downin humans1RR 0.82

1 study
  1. Lifestyle interventions lower the risk of stroke in humans (RR 0.82).

    Review

More on Stroke

Cardiovascular mortality

downin humans1RR 0.84

1 study
  1. Lifestyle interventions lower the risk of cardiovascular mortality in humans (RR 0.84).

    Review

Major adverse cardiovascular events

downin humans1RR 0.85

1 study
  1. Lifestyle interventions lower the risk of major adverse cardiovascular events in humans (RR 0.85).

    Review

Anti-obesity medications

upin humans1

1 study
  1. Anti-obesity medications are associated with lifestyle interventions in humans (adjunct to obesity management medications in Phase 3 trials).

    Reviewadjunct to obesity management medications in Phase 3 trials

More on Anti-obesity medications

Stroke and recurrent stroke events

downin humans1

1 study
  1. Lifestyle interventions are associated with stroke and recurrent stroke events in humans (primary and secondary stroke prevention).

    Reviewprimary and secondary stroke prevention

More on Stroke and recurrent stroke events

Dementia

downin silico1

1 study
  1. Lifestyle interventions lower the risk of dementia in silico.

    In silico

More on Dementia

Alzheimer's disease

downin humans1

1 study
  1. Lifestyle interventions lower the risk of Alzheimer's disease in humans.

    Review

More on Alzheimer's disease

Funding

17 grants since 2016

National Institute on Aging$9.7MNational Center for Chronic Disease Prev and Health Promo$3.1MNational Institute for Health Research£2.3M

Latest

Dec 2025: 2Jan 2026: 8Feb 2026: 6Mar 2026: 3Apr 2026: 4May 2026: 1Jun 2026: 2Jul 2026: 2Aug 2026: 4Sep 2026: 2Oct 2026: 12Nov 2026: 1157 papers in 12 months

See all 81 papers on lifestyle interventions